Strategic Acquisitions Pharmaq AS has actively expanded its market presence through key acquisitions such as Fishvetgroup and Vaksinering, enhancing its product portfolio and manufacturing capabilities, which indicates ongoing growth opportunities and potential for supplying complementary biotech solutions.

Global Expansion The company extended its operations internationally with facility expansions in Norway, indicating a focus on meeting rising demand in aquaculture vaccines and creating opportunities for supply chain partnerships and regional market development.

Market Focus Specializing in aquaculture vaccines and vaccination machinery, Pharmaq’s niche focus aligns well with the expanding aquaculture industry, presenting opportunities to introduce innovative biotech products to a growing sector with increasing health and safety needs.

Parent Company Integration As a part of Zoetis, Pharmaq benefits from strong backing and industry positioning, opening avenues for joint ventures, co-marketing, and access to a global network of veterinary and biotech clients.

Emerging Revenue Potential With a revenue of up to 1 million dollars and ongoing investments, Pharmaq presents growth opportunities for biotech suppliers and partners focused on animal health solutions, especially those targeting aquaculture markets and regional supply chains.